Supplementary Table 2 from The KRAS-Variant and Cetuximab in HPV-Positive Oropharyngeal Cancer: Results from the NRG/RTOG 1016 Trial
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Patient and Tumor Characteristics by KRAS and Assigned Treatment
Fields of Study & Subjects
Head and Neck Cancer Studies
Esophageal Cancer Research and Treatment
Cervical Cancer and HPV Research
Publication details
- Publication date
- 31 March 2026
- Language
- EN